1Mby1M Virtual Accelerator Investor Forum: With Rajeev Singh-Morales, Founder and Managing Partner at Alma Mundi Ventures (Part 4)

Sramana Mitra: When it comes to some of the patient monitoring stuff, which is a very active category, all applications of information technology, especially the AI algorithm in drug discovery, how do you view the role of FDA or an equivalent regulatory body? Rajeev Singh-Morales: I’ll be very candid. I’m not an expert on FDA

Read Full Article »

1Mby1M Virtual Accelerator Investor Forum: With Rajeev Singh-Morales, Founder and Managing Partner at Alma Mundi Ventures (Part 3)

Sramana Mitra: What trends do you see in your deal flow?  Rajeev Singh-Morales: We are a fund that is mostly B2B. We don’t a have an industry focus. There are certain areas in pharma and biotech which are extraordinarily hot right now. We don’t invest in that. We do invest in digital health. That is

Read Full Article »

1Mby1M Virtual Accelerator Investor Forum: With Rajeev Singh-Morales, Founder and Managing Partner at Alma Mundi Ventures (Part 2)

Sramana Mitra: Talk about the companies themselves. Rajeev Singh-Morales: Let me start with one that was just sold about two months ago. Returnly is a firm that we invested in five years ago. It was sold to Affirm for $300 million. It was founded in 2014 by an immigrant from Spain. We invested in 2015

Read Full Article »

1Mby1M Virtual Accelerator Investor Forum: With Rajeev Singh-Morales, Founder and Managing Partner at Alma Mundi Ventures (Part 1)

Rajeev Singh-Morales, Founder and Managing Partner at Alma Mundi Ventures, discusses the Europe – US bridge for tech startups. Sramana Mitra: Your name is so interesting. It seems like there is a whole story in your name and your firm’s name. Do you want to start with a little bit of background?